auto_awesome
Want to know who else bid on this?
ProposalForge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Variation Biotechnologies Inc.Amount
$56.0M
Program
SIF Stream2- GrowthProvince
ONType
Contribution
Agreement Number
033-2020-2021-Q2-815774
Purpose
A project to support the development of Canada's medical countermeasures (MCMs) in immediate response to COVID-19. Variation Biotechnologies Inc. (VBI) will advance the development of an enveloped Virus-Like-Particle (eVLP) vaccine candidate for COVID-19 through clinical trials.
Variation Biotechnologies Inc. × Innovation, Science and Economic Development Canada
3 grants totalling $167.9M
SIF Stream2- Growth
63 grants totalling $4.5B
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| ArcelorMittal Dofasco G.P. | $450.0M | SIF Stream2- Growth |
| ArcelorMittal Dofasco G.P. | $450.0M | SIF Stream2- Growth |
| ArcelorMittal Dofasco G.P. | $400.0M | SIF Stream2- Growth |
| Air Products Canada LTD | $300.0M | SIF Stream2- Growth |
| Cohere Inc. | $240.0M | SIF Stream2- Growth |